Advancements in Capecitabine-Loaded Nanocomposites as a Cutting-Edge Cancer Therapy- A Review

These days, cancers are one of the major reasons of death among humans worldwide. Thus, scientists and researchers are trying to employ applicable techniques to treat cancers more efficiently with lower side effects. On this occasion, various nanoparticles as potential nanocarriers have been used to load anti-cancer drugs to ameliorate the drug delivery restrictions in chemotherapeutic procedures. In the current study, capecitabine (CAP) as a prodrug has been introduced, and the application of diverse capecitabine-loaded nanoparticles for treating cancers such as breast or colorectal cancer has been reviewed. Besides, the co-delivery capability of CAP with other drugs in a stimuli-responsive manner has made these drug-loaded nanoparticles a potential candidate for drug delivery purposes, especially for treating cancers more efficiently.